Initiation of renal replacement therapy impacts HRQoL

Initiation of renal replacement therapy impacts HRQoL

(HealthDay)—The initiation of renal replacement therapy (RRT) impacts health-related quality of life (HRQL) among patients with end-stage kidney disease, according to a study published online Feb. 27 in the Journal of Renal Care.

Ana Rebollo Rubio, from the Carlos Haya Regional University Hospital in Málaga, Spain, and colleagues examined HRQL and at the start of RRT in an observational descriptive study. Data were included for 152 patients starting RRT.

The researchers found that initiation of RRT significantly affected HRQL in patients with end-stage in all respects. Overall, 26.6 and 27 percent of patients experienced states of anxiety and depression, respectively. There was a significant association for these states with the emotional component of quality of life.

"The initiation of RRT has a strong impact on HRQL in comparison with a reference population and with other stages of ," the authors write. "The early detection of an altered is important, as this condition should be treated from the first stages of the disease, as it can significantly affect the subsequent development of RRT and the patient's quality of life."

Explore further

Early renal replacement therapy ups survival in severe AKI

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Initiation of renal replacement therapy impacts HRQoL (2017, March 17) retrieved 19 August 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors